BamSEC and AlphaSense Join Forces
Learn More

Palisade Bio Inc.

NASDAQ: PALI    
Share price (12/20/24): $1.75    
Market cap (12/20/24): $2.327 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.01
from 8-K 3 pages Re: Amendment to Existing Warrants Dear Holder: Reference Is Hereby Made to the Offering on Form S-1 (File No. 333-282883) on or About the Date Hereof (The “Offering”) by Palisade Bio, Inc. (The “Company”) of Its Common Stock, Par Value $0.01 Per Share (“Common Stock”), and/or Other Securities of the Company (Collectively, the “Securities”)
12/34/56
EX-10.50
from POS AM 3 pages Re: Amendment to Existing Warrants Dear Holder: Reference Is Hereby Made to the Offering on Form S-1 (File No. 333-282883) on or About the Date Hereof (The “Offering”) by Palisade Bio, Inc. (The “Company”) of Its Common Stock, Par Value $0.01 Per Share (“Common Stock”), and/or Other Securities of the Company (Collectively, the “Securities”)
12/34/56
EX-10.01
from 8-K 13 pages Palisade Bio, Inc. Executive Employment Agreement
12/34/56
EX-10.48
from 10-Q 11 pages First Amendment to Research Collaboration and License Agreement
12/34/56
EX-10.3
from 8-K 10 pages Placement Agency Agreement
12/34/56
EX-10.2
from 8-K 27 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.01
from 8-K 7 pages Holder of Common Stock Purchase Warrants Issued on May 10, 2022, January 4, 2023, and April 5, 2023 Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.02
from 8-K 16 pages Placement Agency Agreement
12/34/56
EX-10.01
from 8-K 33 pages Securities Purchase Agreement
12/34/56
EX-10.01
from 8-K 13 pages Palisade Bio, Inc. Executive Employment Agreement
12/34/56
EX-10.01
from 8-K 43 pages Research Collaboration and License Agreement Between Palisade Bio, Inc. and Giiant Pharma, Inc. Research Collaboration and License Agreement
12/34/56
EX-10.20
from 10-Q 33 pages Palisade Bio, Inc. 2021 Inducement Plan Adopted by the Board of Directors: November 18, 2021 Amended by the Board of Directors: August 7, 2023
12/34/56
EX-10.02
from 8-K 10 pages Palisade Bio, Inc. 2021 Employee Stock Purchase Plan Adopted by the Board of Directors: February 9, 2021 Approved by the Stockholders: April 9, 2021 Amended by the Stockholders: June 8, 2023
12/34/56
EX-10.01
from 8-K 23 pages Palisade Bio, Inc. 2021 Equity Incentive Plan Adopted by the Board of Directors: February 9, 2021 Approved by the Stockholders: April 9, 2021 Amended by the Stockholders: November 18, 2021 Amended by the Stockholders: June 8, 2023
12/34/56
EX-10.03
from 8-K 16 pages Placement Agency Agreement , 2023
12/34/56
EX-10.02
from 8-K 25 pages Registration Rights Agreement
12/34/56
EX-10.01
from 8-K 42 pages Securities Purchase Agreement
12/34/56
EX-10
from 10-K 8 pages Consulting Agreement
12/34/56
EX-10
from 10-K 4 pages First Amendment to Consulting Agreement
12/34/56